Applications in the Cancer Treatment to Drive the Global Nanomedicine Market Growth

Published: May 2021

The global Nanomedicine market is anticipated to grow significantly at a CAGR of 11.1% over the forecast period (2021-2027). Nanomedicine plays a vital role in drug delivery and regenerative medicines. The key aspect that drives the growth of the global Nanomedicine market is the various benefits and applications of nanomedicines. For instance, nanomedicine for anti-cancer chemotherapy, as cell-based nanomedicines are efficient for cancer chemotherapy. Exosomes contain various molecular elements of the cell including proteins and RNA, which are utilized with synthetic nanomaterial as carrier’s anticancer drugs. 

Browse the full report description Global Nanomedicines Market Size, Share & Trends Analysis Report By Indication Type (Cardiovascular Diseases, Neurological Diseases, Infectious Diseases, Oncological Diseases, Orthopedic Diseases, and Other Diseases (Urological Disease, Ophthalmic Diseases)), and by Application (Drug Delivery, Active Implants, Vaccines, Diagnostic Imaging, Biomaterials, Regenerative Medicines, and Other Applications (Tissue Regeneration)) Forecast, 2021-2027 at https://www.omrglobal.com/industry-reports/nanomedicines-market

Further, nanomedicines are also used in therapeutics for treating cancer. The gold nanoshells are targeted to bond to the cancerous cells. By causing irradiating the area of the tumor with infrared lasers, as which passes through the flesh without heating it and the gold is heated sufficiently to cause death to the cancer cells. Hence, such research activities are likely to provide growth opportunities for the market over the forecast period. Besides, the presence of the key players, continuously innovating novel technologies, and R&D activities also enhance the market growth. Players such as 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc among others are substantially contributing to the market growth. 

Market Coverage

  • Market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- By Indication Type and By Applications
  • Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
  • Competitive Landscape- 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc among others

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment/region dominates the market in base year?
  • Which segment/region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region/segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Nanomedicine Market – Segmentation

By Indication Type

  • Cardiovascular Diseases
  • Neurological Diseases
  • Infectious Diseases
  • Oncological Diseases
  • Orthopedic Diseases
  • Other Diseases (Urological Disease, Ophthalmic Diseases)

By Application

  • Drug Delivery
  • Active Implants
  • Vaccines
  • Diagnostic Imaging
  • Biomaterials
  • Regenerative Medicines
  • Other Applications (Tissue Regeneration)

Global Nanomedicine Market – Segmentation by Region 

North America           

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific    

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World 

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/nanomedicines-market